Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Resources Medical Holdings CoFRA:1PH -1.42%58 5-Year Yield-on-Cost % is 7.05 as of Aug. 02, 2026, which is 213% above its 10-year median of 2.25. GuruFocus rates FRA:1PH with a GF Score™ of 58/100 and a GF Value™ of €0.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 275 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 83.64% on this metric.
The historical rank and industry rank for China Resources Medical Holdings Co's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:1PH'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41 Med: 2.25 Max: 7.25
Current: 7.05
During the past 13 years, China Resources Medical Holdings Co's highest Yield on Cost was 7.25. The lowest was 0.41. And the median was 2.25.
FRA:1PH's 5-Year Yield-on-Cost % is ranked better than 83.64% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.99
vs FRA:1PH: 7.05
China Resources Medical Holdings Co (FRA:1PH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
China Resources Medical Holdings Co 5-Year Yield-on-Cost % Related Terms
FRA:1PH vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's 5-Year Yield-on-Cost % falls into.
China Resources Medical Holdings Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
China Resources Medical Holdings Co (FRA:1PH) has a 5-Year Yield-on-Cost % of 7.05 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Resources Medical Holdings Co and its competitors. This is 213% above median its historical median of 2.25. Over the past decade, China Resources Medical Holdings Co's 5-Year Yield-on-Cost % has ranged from 0.41 to 7.25. According to the industry distribution chart, China Resources Medical Holdings Co ranks #45 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is China Resources Medical Holdings Co's 5-Year Yield-on-Cost % too high?
China Resources Medical Holdings Co's current 5-Year Yield-on-Cost % of 7.05 is 213% above median its 10-year median of 2.25. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 7.25. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.99. China Resources Medical Holdings Co's value of 7.05 is 135.8% above this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #45 out of 275 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Medical Holdings Co has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #45 out of 275 companies for 5-Year Yield-on-Cost %. This places China Resources Medical Holdings Co in the top 16% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.99. China Resources Medical Holdings Co's value of 7.05 is 135.8% above this benchmark. Historically, China Resources Medical Holdings Co's own 5-Year Yield-on-Cost % has ranged from 0.41 to 7.25 over the past decade. While the company's 10-year median is 2.25 vs. the industry median of 2.99, China Resources Medical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current 5-Year Yield-on-Cost % of 7.05 is 135.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current 5-Year Yield-on-Cost % is 7.05, which is 213% above median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Medical Holdings Co (FRA:1PH) is currently considered Possible Value Trap. The stock's GF Value™ is €0.43, compared to a current price of €0.28 — trading 35.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 7.05, which is 213% above median its 10-year median of 2.25 and 135.8% above the Healthcare Providers & Services industry median of 2.99. China Resources Medical Holdings Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For China Resources Medical Holdings Co (FRA:1PH), the current 5-Year Yield-on-Cost % is 7.05 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (FRA:1PH) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of €0.28 is trading 35.3% below its estimated GF Value™ of €0.43.
GuruFocus considers China Resources Medical Holdings Co to be Possible Value Trap.
Key valuation signals for FRA:1PH:
5-Year Yield-on-Cost %: 7.05 (213% above median its 10-year median of 2.25)
GF Value™: €0.43 vs. price of €0.28 (35.3% below fair value)
Industry Position: 135.8% above the Healthcare Providers & Services median (#45 of 275)
No single metric tells the full story. See the FRA:1PH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
58GF Score
Get the complete analysis for FRA:1PH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1PH has been successfully added to your 
